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Objectives: To evaluate the feasibility in a pilot study of in vitro endothelialisation f PTFE grafts used asinterposition 
arteriovenous fi tulas in uraemic patients. 
Methods: Autologous saphenous vein endothelial cells were harvested and cultured on PTFE grafts in seven patients 
undergoing maintenance haemodialysis. The patients had several previous failures of vascular access ites. The patients 
were followed with duplex ultrasound, clinical examination and n one case an explanted graft was examined. 
Results: At the end of follow-up four of the seven patients had patent grafts. One patient occluded the graft immediately 
postoperatively and another after 3.5 months. The form r patient received a second endothelialised graft. In two further 
patients revision f the outflow was performed. In two patients a functioning raft was excised, in one case because of 
bleeding of a venous aneurysm and in one case because of suspected infection. The former which was excised 5 weeks 
postoperatively revealed that 85% of the surface was covered by endothelial cells. 
Conclusions: This pilot study shows that in vitro endothelialisation f PTFE grafts used for haemodialysis is possible 
in uraemic patients. In this highly problematic patient group the results are promising with endothelial cell coverage 
after 5 weeks of implantation. 
Introduction 
In order to overcome the thrombogenicity of synthetic 
vascular grafts, endothelial cell seeding has been sug- 
gested. This was initially done as a one stage pro- 
cedure, seeding the graft at the time of implantation. 
Even when the graft is seeded with cells at a high 
density, there is a critical period before coverage with 
a non-thrombogenic monolayer of endothelial cells 
occurs. 1There is also a critical initial amount of cells 
needed in order to eventually obtain a complete ndo- 
thelial cell monolayer. 2'3 One stage seeding has been 
associated with difficulties and has mostly produced 
disappointing results. 4 In order to overcome the dif- 
ficulties with one stage seeding and to eliminate the 
period between seeding and development of a con- 
fluent cell-layer, two methods have been developed. 
One alternative is to seed massive amounts of micro- 
vascular cells obtained from adipose tissue, s'6 It has, 
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however, been suggested that these cells are of meso- 
thelial origin 7"8 and there is also a risk that fibroblasts 
or smooth muscle cells present as contaminants out- 
grow the endothelial cells. 
An alternative is to harvest a small number of 
endothelial cells which are grown in culture and even- 
tually seeded on the graft where they produce a con- 
fluent layer before implantation of the graft. 9-n This 
method has been termed in vitro endothelialisation 
(IVE). In order to decrease the time it takes to produce 
a completely covered graft, agents that increase cAMP 
have been used for the culture. 12 This method using 
the patient's own serum as a growth medium has been 
adapted for IVE of ePTFE grafts. 13'14 
Patients undergoing haemodialysis need a vascular 
access site with a large blood flow. The primary pro- 
cedure is to arterialise a vein by creating an arterio- 
venous (AV) fistula at the wrist. 1~ Should this procedure 
fail, most centres use an interposition graft between 
the brachial artery and an antecubital vein. The graft, 
which is shaped in loop configuration, is punctured 
during the dialysis. The grafts often develop stenoses 
either within the graft or, more commonly, at the 
venous  outflow. 16A7 
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Table 1. Summary of patient characteristics. 
Patient no 1 2 3 4 5 6 7 
Sex M F F F F F M 
Age (years) 72 74 49 64 53 69 66 
Years on haemodialysis 4 2 1 1 2.5 3 2.5 
No. of previous fistula/grafts 3 5 1 1 3 3 2 
No. of revisions of access sites 5 6 0 2 3 4 1 
No. central dialysis catheter >4 1 1 2 3 >5 1 
In the present study we report the experience of 
IVE of ePTFE interposition loop graft AV-fistulas in 
uraemic patients. This patient group was ~elected for 
our initial clinical attempts with IVE grafts because 
they represent a problem because of numerous throm- 
botic complications. Furthermore the risk for the 
patient in the event of graft occlusion is not life- 
threatening. 
Patients 
This report concerns even patients on maintenance 
haemodialysis (five women and two men) ranging in 
age between 49-74 years. The patients all had multiple 
previous recurrent problems with their haemodialysis 
access sites including numerous thrombotic com- 
plications. In addition they had also been treated with 
central .dialysis catheters everal times in order to 
enable haemodialysis when the ordinary fistula or 
graft had failed. As a reflection of the problematic 
nature of these patients the average number of re- 
visions for their access sites was three, including 
thrombectomies and revisions of the venous outflow. 
They had been on haemodialysis treatment for an 
average of 2.3 years (range 1-4). A summary of their 
previous medical history regarding access ites is given 
in Table 1. The weekly dialysis time was 9-12 h. The 
dialysers used were polysulphon hollow fibre (Fre- 
senius). The dialyser area ranges from 0.7 to 1.3 m 2. 
Single pass dialysis systems were used with bi- 
carbonate as the dialysis buffer. The blood flow during 
dialysis was 155-300 ml/min.  All patients were treated 
with recombinant human erythropoietin 40-50 units/  
kg body weight administered intravenously three 
times weekly after dialysis. The haemoglobin con- 
centration ranged from 62 to 113 g/1. 
Informed consent was obtained and the study was 
approved by the Local Ethics Committee. 
Methods 
Culture of endothelial cells 
A segment of the saphenous vein, or in some cases 
the external jugular vein, approximately 5 cm long 
was carefully excised under local anaesthesia s a 
source of endothelial cells. The vein was filled with 
collagenase (0.1% Worthington, Freehold, NJ, U.S.A.) 
and the harvested cells were cultured in minimal 
essential medium (MEM; Gibco, BRL, Paisley, Scot- 
land) with 40% autologous serum. In order to decrease 
culture time, cAMP elevating compounds - iso-butyl- 
methyl-xantin (IBMX; Sigma, St Louis, MO, U.S.A.) 
and cholera toxin (Sigma) were added as previously 
describedJ 2 The cells were grown for four passages 
using the same conditions and after the fourth passage 
they were transferred to a 6 mm diameter, ePTFE graft 
of 25 cm length. The graft was primed with autologous 
serum, after which the cells were seeded in four quad- 
rants. 14 After 1 day the graft was carefully bent into a 
horse shoe configuration and incubation was con- 
tinued for another day. The average number of cells 
seeded into the graft was 7 million corresponding to 
approximately 200 000 cells/cm 2.The cells were grown 
in the graft in MEM with 30% autologous erum 
without IBMX or cholera toxin. The whole procedure 
was performed under sterile conditions and culture 
medium was sent for analysis of bacterial contaminants 
before the graft was cleared for implantation. 
Surgical procedure 
The loop graft was inserted usually under general 
anaesthesia and in a few cases under brachial plexus 
block. The brachial artery and a suitable vein at the 
elbow level were dissected free. The largest vein avail- 
able was used irrespective of whether this was a 
superficial or a deep vein. A transverse counter incision 
was made approximately 20 cm distal to the incision 
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at the elbow level. The loop graft was then tunnelled 
pulling both ends of the graft simultaneously in order 
to keep the U-shape of the graft intact during the 
tunnelling procedure thereby minimising trauma to 
the inner surface. After positioning of the loop graft, 
both ends were cut and the inner surface of the graft 
was kept moist by flushing it at constant intervals 
with Ringer's solution. An end-to-side anastomosis 
was usually performed first to the side of the brachial 
artery using CV-7 Gore Tex suture. The venous ana- 
stomosis was performed similarly. Blood flow was 
allowed to start gradually by slowly releasing manual 
compression on the brachial artery after completion 
of both anastomoses. During the whole procedure 
extreme care was taken in order not to damage or 
bend the graft and to keep the inner surface moist. 
Both ends of the graft were cut since they had been 
used for handling during the endothelialisation a d 
therefore did not have a cellular coverage. The cut 
ends of the graft were saved and stained with cresyl 
violet to examine if endothelial covering was present 
at the anastomotic sites. 
the time average blood flow velocity (TAV). TAV was 
measured for 5-8 complete cardiac cycles. The mean 
of three measurements of vessel diameter from the B- 
mode image was used for area calculation. Volume 
flow was measured in the mid brachial artery, ap- 
proximately 10 cm above the loop graft anastomosis. 
Volume flow was also estimated in a non-curved seg- 
ment of the graft. 
ImmunohistochemicaI and scanning electron microscopy 
analyses 
Segments from excised grafts from the arterial and 
venous ends and the middle portion of the graft were 
prepared for scaruning electron microscopy (SEM) as 
described by Schroetter et a19 Immunohistochemical 
demonstration of von Willebrand related antigen and 
the basement membrane component collagen type IV 
was performed as previously described. 21
Colour duplex ultrasound 
Duplex scanning was performed with a colour-flow 
duplex imager (Acuson 128, Mountain View, CA, 
U.S.A.). A linear imaging transducer of 5 MHz or 7.5 
MHz was selected in conjunction with a 3.5 MHz or 
5 MHz pulsed Doppler. 
The follow-up program included ultrasonographic 
examinations 1,3, 6, 9 and 12 months postoperatively. 
Six of the patients were subjected to this program. 
Four of them also underwent a preoperative ultra- 
sonographic assessment of the venous system of both 
arms. The follow-up duplex examinations included B- 
mode imaging of morphology and vessel diameter, 
colour-flow Doppler to localise flow abnormalities and 
pulsed Doppler to measure maximal and mean blood 
flow velocities. The scanning included the brachial 
artery from the mid upper arm to the proximal ana- 
stomosis, the whole length of the graft and the efferent 
venous vessels from the venous anastomosis to the 
mid subclavian vein. Angle corrected flow velocities 
(m/s) were measured at a 50-60 degree angle between 
the ultrasonic beam and the length of the blood vessel. 
A localised increase of flow velocity of >/2.5 times 
that in the closest preceding segment I8 was used to 
denote a significant stenosis, at the proximal ana- 
stomosis a velocity ratio of >~ 3.5 was used. 19 
Volume flow measurements were performed by cal- 
culating the product of vessel cross sectional area and 
Results 
Surgery was primarily successful in all patients but 
one where the loop graft occluded immediately post- 
operatively. This patient was later reoperated with a 
second IVE graft. At present, four of the seven patients 
have patent grafts with an observation time of 6 
months in one case, 10 months in two cases and 1 year 
in one case. Apart from the patient where an occlusion 
occurred immediately postoperatively, three other 
grafts failures have been recorded. One patient oc- 
cluded her graft 3.5 months postoperatively. In two 
cases the loop graft had to be removed because of 
bleeding. In one woman rupture of an aneurysm in 
the outflow vein occurred and the graft had to be 
removed 5 weeks postoperatively. SEM of segments 
from the arterial and venous ends and the mid portion 
of the explanted graft revealed that approximately 
85% of the surface was covered by endothelial cells. 
The endothelial nature of the cellular lining was con- 
firmed by a positive staining for von Willebrand an- 
tigen. Antibodies raised against collagen type IV also 
produced a positive staining indicating presence of a 
basement membrane. In one further patient bleeding 
occurred at the venous outflow, it was, however, dif- 
ficult to exactly identify the bleeding source but for 
fear of an infection causing the bleeding, the graft was 
removed. No positive bacterial culture was obtained 
from the latter two patients. 
Among those grafts that are patent, three have been 
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Table 2. Colour duplex evaluation of seven patients operated with endothelialised loop grafts. 
Patient no 1 month 3 months 6 months 9 months 12 months 
1 No significant No significant <50% stenosis in <50% stenosis in <50% proximal 
stenosis stenosis proximal graft proximal graft, graft 
QB = ? QB = 950 ml/min QB = 1170 ml/min 
Vc =2.2 m/s Vc = 1.7 m/s Vc= 2.3 m/s 
>50% stenosis at >50% stenosis at Progression of 
distal anastomosis distal anastomosis stenosis 
QB=690 ml/min 
Vc = 1.7 m/s 
3* No significant 
stenosis 
QB = 1050 ml /min  
VG=2.1 m/s 
4 No significant 
stenosis 
QB = 1100 ml/min 
VG =2.1 m/s 
5 No significant 
stenosis 
QB = 850 ml/min QB = 95 ml/min 
VG=I.8 m/s VG=0 m/s 
6 Graft removed 5
weeks, bleeding no 
duplex 
7 >50% stenosis at Graft removed 
distal anastomosis 
QB = 1150 ml/min 
Vc = 1.7 m/s 
QB = 870 ml/min QB = 710 ml/min 
VG=2.1 m/s VG=I.3 m/s 
Two outflow vein Progression of vein 
stenosis stenosis 
QB = 870 ml/min QB = 710 ml/min 
VG=2.1 m/s Vc=1.3 rn/s 
Stenosis in 1 of 3 Stenoses in 2 of 3 
outflow veins outflow veins 
QB = 875 ml/min QB = 785 ml/min 
Vc = 1.6 m/s VG = 1.5 m/s 
Occluded graft 
Op. false aneurysm 
QB = 1020 ml/min 
V G = 2.5 1Tl/S 
PTA of outflow 
stenosis 
>50% stenosis 
proximal graft 
QB = 950 ml/min 
Vc = 1.6 m/s 
Op. outflow 
revision 
QB=950 ml/min 
Vc = 1.6 m/s 
QB = 1030 ml/min 
VG = 2.1 m/s 
* Patient no. 3 received one graft which occluded immediately postoperatively. The graft listed in the table is the second graft in this 
patient. 
QB = flow in the bracial artery, V c = maximal velocity in a non-curved and non-stenotic segment of the graft. 
subjected to interventions. In one case a false aneurysm 
at a puncture  site was operated 8 months  after the 
original operation. In one case with increasing outf low 
resistance a stenosis of the outf low vein was d iagnosed 
fol lowing surgery. This was treated by  percutaneous 
transluminal  angioplasty. In order not to puncture  the 
seeded graft, the vein was punctured  proximal  to the 
stenosis and the bal loon catheter was introduced in a 
retrograde fashion. Venoplasty was successful. In one 
further case with stenosis of the venous outf low and 
a false aneurysm, surgery was again per formed 9 
months  after the initial surgery. At this operat ion a 
false aneurysm was repaired and the venous outf low 
was reconstructed by interposit ion of a new segment 
of an IVE graft. The new graft was posit ioned between 
the venous  end of the graft and the outf low vein 
proximal  to the previous anastomosis.  The grafts that 
are presently patent are all funct ioning well and sup- 
port ing adequate haemodialysis.  Blood flow at dialysis 
was 330 ml /min ,  which resulted in a venous pressure 
ranging between 180 and 220 mmHg.  
Duplex results for each patient are shown schem- 
atically in Table 2. In general, B-mode imaging showed 
a smooth surface along the graft walls. In two patients, 
however,  small areas with irregular wall structure 
developed at the near wall  at the puncture sites. Mean 
flow velocity in a non-curved and non-stenotic graft 
segment (VG) was 1.9 m/s  (range 1.5-2.4) and vo lume 
flow in the brachial artery (QB) was 905 ml /min  (range 
785-1030) at the end of fol low-up. Volume flow in the 
graft was in general 50-100 m] less than in the brachial 
artery. There was a clear relation between progress ion 
of stenoses and decrease of vo lume flow. 
Discussion 
The present pilot s tudy examines the feasibility of IVE 
in general and for use in loop grafts in uraemic patients 
in particular. The report  shows promis ing results in a 
patient group with many thrombotic  problems. It 
should be remembered that many  of the patients in 
the present s tudy had mult iple previous failures often 
with loop grafts occluding in the early postoperat ive 
per iod after previous attempts. 
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There are several reasons to believe that the coating 
of the grafts with endothelial cells is beneficial for the 
patency. A confluent endothelial cell layer is non- 
thromobogenic provided that the cells have not 
changed their phenotype. 22 An intact endothelial cell 
layer is probably also a prerequisite to prevent myo- 
intimal hyperplasia which usually occurs at the an- 
astomotic sites. The potential advantage with an in 
vitro endothelialised graft is therefore two-fold: it con- 
tributes to decreased thrombogenicity and may also 
prevent myointimal hyperplasia occluding the outflow 
of the graft. Endothelial cells have several built-in non- 
thrombogenic characteristics and it has been shown 
previously that cells seeded on ePTFE with the method 
used in this study are capable of produdng pro- 
stacyclin and tissue plasminogen activator. 23 They fur- 
thermore support inhibition of thrombin and are able 
to activate protein C upon challenge with thrombinJ 4
Intraoperatively seeded grafts have not been shown 
to result in better patency than ordinary graftsJ Zilla 
et al., however, have reported better patency for femo- 
ropopliteal IVE grafts than for ordinary grafts75 In 
that report, however, fibrin glue derived from donor 
blood with the addition of a protease inhibitor was 
used to support adhesion of tee endothelial cells in- 
stead of autologous erum as used in the present 
report. Furthermore another culture medium without 
cAMP-elevating compounds, but with the addition of 
exogenous growth factors, was used in that study, in 
the present study growth of the cells in vitro was 
supported by autologous erum and the fact that the 
patients were uraemic did not seem to influence the 
effect of the autologous serum as a growth promoting 
agent. If these different growth conditions influence 
cellular function after implantation is not known. 
Values from flow measurements in these grafts were 
in the same orders as those presented earlier from 
studies of AV-fistulas and conventional loop grafts. 26 
For example, one study found flow rates of 750 ml/ 
rain in 31 PTFE grafts (6 ram).  27 In this small number 
of patients we found flow measurements u eful in the 
evaluation, especially t° assess the haemodynamic 
effect of stenoses and the timing for surgical inter- 
vention. As shown earlier, careful ultrasonographic 
examination of haemodialysis access ystems will re- 
veal a high number of abnormalities, in our study, as 
in others, these abnormalities were most frequently 
found in the venous/efferent part of the access sys- 
tem. 28'29 Our impression from limited observations i
that wall changes within these PTFE graft was a rather 
uncommon finding, in contrast o what has been ob- 
served earlier in conventional synthetic PTFE loop 
grafts. 26 
In conclusion, the present p~lot study shows prom- 
ising results. From a theoretical point of view and 
based on earlier literature reports with a similar 
method, it is likely that IVE is beneficial and con- 
tributes to better graft patency. However, arandomised 
study is required to prove this and we have recently 
initiated such a study. If it can be shown that IVE 
contributes to better graft patency, such a study may 
also answer the question of whether IVE should be 
used as the standard procedure or be reserved for 
patients with a high risk of thrombotic graft occlusion. 
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